Global Integrin Alpha 4 Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Integrin Alpha 4 market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Integrin Alpha 4 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Integrin Alpha 4 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Integrin Alpha 4 is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Integrin Alpha 4 include Takeda Pharmaceutical Co Ltd, Viriom Inc, Protagonist Therapeutics Inc, Morphic Therapeutic Inc, Immunwork Inc, EA Pharma Co Ltd, Daiichi Sankyo Co Ltd, BioMAS Ltd and Biogen Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Integrin Alpha 4, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Integrin Alpha 4.

The Integrin Alpha 4 market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Integrin Alpha 4 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Integrin Alpha 4 Segment by Company

Takeda Pharmaceutical Co Ltd
Viriom Inc
Protagonist Therapeutics Inc
Morphic Therapeutic Inc
Immunwork Inc
EA Pharma Co Ltd
Daiichi Sankyo Co Ltd
BioMAS Ltd
Biogen Inc
Antisense Therapeutics Ltd
Amgen Inc

Integrin Alpha 4 Segment by Type

ATL-1102
Carotegrast
ET-3764
TE-5232
Others

Integrin Alpha 4 Segment by Application

Acute Ischemic Stroke
Melanoma
Celiac Disease
Multiple Sclerosis
Epilepsy
Other

Integrin Alpha 4 Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrin Alpha 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Integrin Alpha 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrin Alpha 4.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Integrin Alpha 4 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Integrin Alpha 4 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Integrin Alpha 4 Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Integrin Alpha 4 Sales Estimates and Forecasts (2020-2031)
1.3 Integrin Alpha 4 Market by Type
1.3.1 ATL-1102
1.3.2 Carotegrast
1.3.3 ET-3764
1.3.4 TE-5232
1.3.5 Others
1.4 Global Integrin Alpha 4 Market Size by Type
1.4.1 Global Integrin Alpha 4 Market Size Overview by Type (2020-2031)
1.4.2 Global Integrin Alpha 4 Historic Market Size Review by Type (2020-2025)
1.4.3 Global Integrin Alpha 4 Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Integrin Alpha 4 Sales Breakdown by Type (2020-2025)
1.5.2 Europe Integrin Alpha 4 Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Integrin Alpha 4 Sales Breakdown by Type (2020-2025)
1.5.4 South America Integrin Alpha 4 Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Integrin Alpha 4 Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Integrin Alpha 4 Industry Trends
2.2 Integrin Alpha 4 Industry Drivers
2.3 Integrin Alpha 4 Industry Opportunities and Challenges
2.4 Integrin Alpha 4 Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Integrin Alpha 4 Revenue (2020-2025)
3.2 Global Top Players by Integrin Alpha 4 Sales (2020-2025)
3.3 Global Top Players by Integrin Alpha 4 Price (2020-2025)
3.4 Global Integrin Alpha 4 Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Integrin Alpha 4 Major Company Production Sites & Headquarters
3.6 Global Integrin Alpha 4 Company, Product Type & Application
3.7 Global Integrin Alpha 4 Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Integrin Alpha 4 Market CR5 and HHI
3.8.2 Global Top 5 and 10 Integrin Alpha 4 Players Market Share by Revenue in 2024
3.8.3 2023 Integrin Alpha 4 Tier 1, Tier 2, and Tier 3
4 Integrin Alpha 4 Regional Status and Outlook
4.1 Global Integrin Alpha 4 Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Integrin Alpha 4 Historic Market Size by Region
4.2.1 Global Integrin Alpha 4 Sales in Volume by Region (2020-2025)
4.2.2 Global Integrin Alpha 4 Sales in Value by Region (2020-2025)
4.2.3 Global Integrin Alpha 4 Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Integrin Alpha 4 Forecasted Market Size by Region
4.3.1 Global Integrin Alpha 4 Sales in Volume by Region (2026-2031)
4.3.2 Global Integrin Alpha 4 Sales in Value by Region (2026-2031)
4.3.3 Global Integrin Alpha 4 Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Integrin Alpha 4 by Application
5.1 Integrin Alpha 4 Market by Application
5.1.1 Acute Ischemic Stroke
5.1.2 Melanoma
5.1.3 Celiac Disease
5.1.4 Multiple Sclerosis
5.1.5 Epilepsy
5.1.6 Other
5.2 Global Integrin Alpha 4 Market Size by Application
5.2.1 Global Integrin Alpha 4 Market Size Overview by Application (2020-2031)
5.2.2 Global Integrin Alpha 4 Historic Market Size Review by Application (2020-2025)
5.2.3 Global Integrin Alpha 4 Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Integrin Alpha 4 Sales Breakdown by Application (2020-2025)
5.3.2 Europe Integrin Alpha 4 Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Integrin Alpha 4 Sales Breakdown by Application (2020-2025)
5.3.4 South America Integrin Alpha 4 Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Integrin Alpha 4 Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Takeda Pharmaceutical Co Ltd
6.1.1 Takeda Pharmaceutical Co Ltd Comapny Information
6.1.2 Takeda Pharmaceutical Co Ltd Business Overview
6.1.3 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product Portfolio
6.1.5 Takeda Pharmaceutical Co Ltd Recent Developments
6.2 Viriom Inc
6.2.1 Viriom Inc Comapny Information
6.2.2 Viriom Inc Business Overview
6.2.3 Viriom Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Viriom Inc Integrin Alpha 4 Product Portfolio
6.2.5 Viriom Inc Recent Developments
6.3 Protagonist Therapeutics Inc
6.3.1 Protagonist Therapeutics Inc Comapny Information
6.3.2 Protagonist Therapeutics Inc Business Overview
6.3.3 Protagonist Therapeutics Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Protagonist Therapeutics Inc Integrin Alpha 4 Product Portfolio
6.3.5 Protagonist Therapeutics Inc Recent Developments
6.4 Morphic Therapeutic Inc
6.4.1 Morphic Therapeutic Inc Comapny Information
6.4.2 Morphic Therapeutic Inc Business Overview
6.4.3 Morphic Therapeutic Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Morphic Therapeutic Inc Integrin Alpha 4 Product Portfolio
6.4.5 Morphic Therapeutic Inc Recent Developments
6.5 Immunwork Inc
6.5.1 Immunwork Inc Comapny Information
6.5.2 Immunwork Inc Business Overview
6.5.3 Immunwork Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Immunwork Inc Integrin Alpha 4 Product Portfolio
6.5.5 Immunwork Inc Recent Developments
6.6 EA Pharma Co Ltd
6.6.1 EA Pharma Co Ltd Comapny Information
6.6.2 EA Pharma Co Ltd Business Overview
6.6.3 EA Pharma Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.6.4 EA Pharma Co Ltd Integrin Alpha 4 Product Portfolio
6.6.5 EA Pharma Co Ltd Recent Developments
6.7 Daiichi Sankyo Co Ltd
6.7.1 Daiichi Sankyo Co Ltd Comapny Information
6.7.2 Daiichi Sankyo Co Ltd Business Overview
6.7.3 Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Daiichi Sankyo Co Ltd Integrin Alpha 4 Product Portfolio
6.7.5 Daiichi Sankyo Co Ltd Recent Developments
6.8 BioMAS Ltd
6.8.1 BioMAS Ltd Comapny Information
6.8.2 BioMAS Ltd Business Overview
6.8.3 BioMAS Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BioMAS Ltd Integrin Alpha 4 Product Portfolio
6.8.5 BioMAS Ltd Recent Developments
6.9 Biogen Inc
6.9.1 Biogen Inc Comapny Information
6.9.2 Biogen Inc Business Overview
6.9.3 Biogen Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Biogen Inc Integrin Alpha 4 Product Portfolio
6.9.5 Biogen Inc Recent Developments
6.10 Antisense Therapeutics Ltd
6.10.1 Antisense Therapeutics Ltd Comapny Information
6.10.2 Antisense Therapeutics Ltd Business Overview
6.10.3 Antisense Therapeutics Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Antisense Therapeutics Ltd Integrin Alpha 4 Product Portfolio
6.10.5 Antisense Therapeutics Ltd Recent Developments
6.11 Amgen Inc
6.11.1 Amgen Inc Comapny Information
6.11.2 Amgen Inc Business Overview
6.11.3 Amgen Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Amgen Inc Integrin Alpha 4 Product Portfolio
6.11.5 Amgen Inc Recent Developments
7 North America by Country
7.1 North America Integrin Alpha 4 Sales by Country
7.1.1 North America Integrin Alpha 4 Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Integrin Alpha 4 Sales by Country (2020-2025)
7.1.3 North America Integrin Alpha 4 Sales Forecast by Country (2026-2031)
7.2 North America Integrin Alpha 4 Market Size by Country
7.2.1 North America Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Integrin Alpha 4 Market Size by Country (2020-2025)
7.2.3 North America Integrin Alpha 4 Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Integrin Alpha 4 Sales by Country
8.1.1 Europe Integrin Alpha 4 Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Integrin Alpha 4 Sales by Country (2020-2025)
8.1.3 Europe Integrin Alpha 4 Sales Forecast by Country (2026-2031)
8.2 Europe Integrin Alpha 4 Market Size by Country
8.2.1 Europe Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Integrin Alpha 4 Market Size by Country (2020-2025)
8.2.3 Europe Integrin Alpha 4 Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Integrin Alpha 4 Sales by Country
9.1.1 Asia-Pacific Integrin Alpha 4 Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Integrin Alpha 4 Sales by Country (2020-2025)
9.1.3 Asia-Pacific Integrin Alpha 4 Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Integrin Alpha 4 Market Size by Country
9.2.1 Asia-Pacific Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Integrin Alpha 4 Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Integrin Alpha 4 Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Integrin Alpha 4 Sales by Country
10.1.1 South America Integrin Alpha 4 Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Integrin Alpha 4 Sales by Country (2020-2025)
10.1.3 South America Integrin Alpha 4 Sales Forecast by Country (2026-2031)
10.2 South America Integrin Alpha 4 Market Size by Country
10.2.1 South America Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Integrin Alpha 4 Market Size by Country (2020-2025)
10.2.3 South America Integrin Alpha 4 Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Integrin Alpha 4 Sales by Country
11.1.1 Middle East and Africa Integrin Alpha 4 Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Integrin Alpha 4 Sales by Country (2020-2025)
11.1.3 Middle East and Africa Integrin Alpha 4 Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Integrin Alpha 4 Market Size by Country
11.2.1 Middle East and Africa Integrin Alpha 4 Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Integrin Alpha 4 Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Integrin Alpha 4 Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Integrin Alpha 4 Value Chain Analysis
12.1.1 Integrin Alpha 4 Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Integrin Alpha 4 Production Mode & Process
12.2 Integrin Alpha 4 Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Integrin Alpha 4 Distributors
12.2.3 Integrin Alpha 4 Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings